Dynamic of Pediatric Invasive Bacterial Infections in Switzerland: A 2017-2024 Time-series Analysis of National Data

Manon Jaboyedoff1, Anita Niederer-Loher2, Christian R Kahlert2

  • 1From the Department Women-Mother-Child, Unit of Pediatric Infectious Diseases and Vaccinology, Service of Pediatrics, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Insights

Vaccine-preventable invasive bacterial infections (IBIs) in children were less impacted by COVID-19 public health measures than invasive group A streptococcal infections. This highlights differing bacterial pathogen responses to interventions.

Area of Science:

  • Pediatric infectious diseases
  • Epidemiology
  • Public health interventions

Background:

  • The coronavirus disease 2019 (COVID-19) pandemic prompted widespread nonpharmaceutical interventions (NPIs).
  • The impact of these NPIs on various bacterial infections, particularly in pediatric populations, remains incompletely understood.
  • Invasive bacterial infections (IBIs) represent a significant global health concern in children.

Purpose of the Study:

  • To compare the effect of NPIs during the COVID-19 pandemic on vaccine-preventable IBIs versus invasive group A streptococcal (iGAS) infections in Swiss children.
  • To analyze the distinct epidemiological dynamics of different bacterial pathogens in response to public health measures.

Main Methods:

  • Nationwide, population-based, time-series analysis.
  • Utilized data on IBIs in children across Switzerland.
  • Compared incidence trends of specific bacterial pathogens before and during the COVID-19 pandemic.

Main Results:

  • Vaccine-preventable IBIs demonstrated resilience to NPIs implemented during the COVID-19 pandemic.
  • Invasive group A streptococcal infections showed a more pronounced response to the NPIs compared to vaccine-preventable IBIs.
  • Epidemiological patterns of bacterial pathogens varied significantly in their susceptibility to public health interventions.

Conclusions:

  • The study underscores that different bacterial pathogens exhibit unique responses to nonpharmaceutical interventions.
  • Findings suggest that the impact of public health measures on pediatric bacterial infections is pathogen-specific.
  • Further research into pathogen-specific dynamics is crucial for effective public health strategies against bacterial infections.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.3K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
249
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
575
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
258
Infection01:20

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
11.9K